» Articles » PMID: 24250444

Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones AsPotassium Channel Openers in Isolated Rat Aorta

Overview
Publisher Brieflands
Specialty Pharmacology
Date 2013 Nov 20
PMID 24250444
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

ATP-sensitive potassium (KATP) channel openers have a relaxation effect due to the lower cellular membrane potential and inhibit calcium influx. There has been considerable interest in exploring KATP channel openers in the treatment of various diseases such as cardiovascular, cerebrovascular, and urinary system disease and premature labor. The purpose of this study was to synthesize 3,3,6,6-tetramethy l-9-aryl-octahydro-1,8-acridindiones and investigate their effects on vascular potassium channels and mechanism of induced relaxations on phenylephrine-induced contractile responses in isolated rings of rat aortic smooth muscle. In this study, four new derivatives of 3,3,6,6-tetramethy l-9-aryl-octahydro-1,8-acridindione [2a-d] were synthesized by the reaction of 5, 5-dimethyl-1,3-cyclohexanedione with an aromatic aldehyde, 2-alkylthio-1-(4-fluorobenzyl)-5-formylimidazole or 3-substituted benzaldehyde, in the presence of ammonia in methanol. Their effects on vascular potassium channels and mechanism of induced relaxations on phenylephrine-induced contractile responses in isolated rat aorta were investigated. Minoxidil was used as a standard potassium channel opener and Glibenclamide was used as a standard potassium channel blocker. The effects of compounds on KCl-induced contractile response which is an indicator of ca-channel blocking activity was also investigated and compared to that of nifedipine as a standard calcium channel blocker. Compounds 3a-d and Minoxidil relaxed the contractions exerted by using phenylephrine with the potency order as follows: Minoxidil > 3c > 3d > 3a > 3b. This effect was sensitive to the potassium channel blocker Glibenclamide. It can be concluded that these compounds act via ATP-sensitive potassium (KATP) channels. Selectivity index (SI) for these compounds and Minoxidil also shows that these compounds are selective to ATP-sensitive potassium (KATP) channels and the selectivity of compounds 3a-d is less than Minoxidil.

Citing Articles

Applications and efficacy of minoxidil in dermatology.

Hussein R, Dayel S, Abahussein O, Ali El-Sherbiny A Skin Health Dis. 2024; 4(6):e472.

PMID: 39624749 PMC: 11608877. DOI: 10.1002/ski2.472.


Synthesis of novel 1,8-acridinediones derivatives: Investigation of MDR reversibility on breast cancer cell lines T47D and tamoxifen-resistant T47D.

Moallem S, Dehghani N, Mehri S, Shahsavand S, Alibolandi M, Hadizadeh F Res Pharm Sci. 2015; 10(3):214-21.

PMID: 26600848 PMC: 4621628.


Effects of minoxidil gel on burn wound healing in rats.

Khazaeli P, Karamouzian M, Rohani S, Sadeghirad B, Ghalekhani N Iran J Pharm Res. 2014; 13(1):243-51.

PMID: 24734077 PMC: 3985251.

References
1.
Jovanovic S, Jovanovic A . Pinacidil prevents membrane depolarisation and intracellular Ca2+ loading in single cardiomyocytes exposed to severe metabolic stress. Int J Mol Med. 2001; 7(6):639-43. DOI: 10.3892/ijmm.7.6.639. View

2.
LOEV B, Goodman M, Snader M, Tedeschi R, MACKO E . "Hantzsch-type" dihydropyridine hypotensive agents. 3. J Med Chem. 1974; 17(9):956-65. DOI: 10.1021/jm00255a010. View

3.
Horiuchi T, DIETRICH H, Tsugane S, Dacey Jr R . Role of potassium channels in regulation of brain arteriolar tone: comparison of cerebrum versus brain stem. Stroke. 2001; 32(1):218-24. DOI: 10.1161/01.str.32.1.218. View

4.
Yagupolskii L, Antepohl W, Artunc F, Handrock R, KLEBANOV B, Maletina I . Vasorelaxation by new hybrid compounds containing dihydropyridine and pinacidil-like moieties. J Med Chem. 1999; 42(25):5266-71. DOI: 10.1021/jm990443h. View

5.
Berkan O, Sarac B, Simsek R, Yildirim S, Sarioglu Y, Safak C . Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries. Eur J Med Chem. 2002; 37(6):519-23. DOI: 10.1016/s0223-5234(02)01374-0. View